Company intelligence / Profile preview

Astra Arcus

Södertälje, Sweden

Ownership: Private
Development stage: Other

Overview

Astra Arcus was a specialized research and development subsidiary of the Swedish pharmaceutical giant Astra AB, primarily focused on the central nervous system (CNS) and pain management. Established in 1991 and based in Södertälje, Sweden, the company was one of Astra's core research units alongside Astra Draco and Astra Hässle. Its portfolio included significant research into neurodegenerative diseases such as Alzheimer's and Parkinson's, as well as psychiatric disorders and chronic pain. Following the 1999 merger between Astra AB and Zeneca Group, Astra Arcus was fully integrated into the newly formed AstraZeneca. The entity's legacy remains foundational to AstraZeneca's historical and ongoing contributions to neuroscience and analgesic medicine.

Therapeutic areas: PsychiatryNeurology
Modalities: Small molecule
Industry: Pharma

Beyond the preview

Go deeper on Astra Arcus.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Astra Arcus.

Explore the full profile